We are live on ! Find out more
GOVX icon

GeoVax Labs

15 hedge funds and large institutions have $478K invested in GeoVax Labs in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

15% more funds holding

Funds holding: 13 → 15 (+2)

5.01% less ownership

Funds ownership: 8.48% → 3.47% (-5%)

83% less capital inflows, than outflows

Capital inflows: $138K | Capital outflows: $799K

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GOVX Hedge Fund Activity: Q2 2025 in Review

15 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q2 2025, worth a combined $478K — down 62% from $1.24M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new GOVX positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, adding an estimated $109K. The largest seller was Armistice Capital, exiting entirely with an estimated $703K sold.

  • 15 institutional investors held GeoVax Labs (GOVX) as of Q2 2025, up from 13 in Q1 2025.
  • Funds reported $478K of GeoVax Labs stock for Q2 2025, down 62% quarter-over-quarter.
  • 5 funds opened new GeoVax Labs positions in Q2 2025 and 3 closed out, a net change of +2 holders.
  • The largest GeoVax Labs buyer in Q2 2025 was UBS Group, an estimated $109K added.
  • The largest GeoVax Labs seller in Q2 2025 was Armistice Capital, an estimated $703K sold.

Based on aggregated 13F filings for Q2 2025.